Yes, nerve-sparing surgery is possible for many prostate cancer patients, provided the tumour hasn’t grown into the neurovascular bundles running along either side of the gland. Not always, though. It’s a case-by-case call. The decision comes down to cancer stage, tumour location, and how aggressive things look on biopsy. When it’s feasible, surgeons preserve the nerves that handle erectile function and continence while still clearing the cancer completely. When it isn’t, complete removal wins. Every time.

According to Prof. Dr. Sandeep Nayak, Robotic Cancer Surgery in Bangalore, “Nerve sparing only works when the cancer’s location actually allows it, and that’s something the anatomy on the table decides, not the scan taken beforehand.”

A handful of concrete factors decide this. Case by case, never by default.

• Tumour location. If the cancer sits close to where the neurovascular bundles run, surgeons often sacrifice function on that side to stay ahead of the disease.
• Cancer stage. Early, organ-confined tumours leave far more room to work with than disease that’s already pushed past the capsule.
• Gleason score. Because leaving cancer behind costs more than losing function ever would, higher grade disease pushes surgeons toward a wider resection margin.
• Baseline function. Men with some erectile difficulty going in simply don’t gain as much from nerve sparing, so that gets weighed upfront, honestly.

A detailed prostate evaluation covering imaging and biopsy mapping decides this, not guesswork, before surgery ever begins.

Results vary considerably here. Worth being honest about that range instead of promising a number that won’t hold for everyone.

• Bilateral sparing. Preserving both neurovascular bundles pushes potency recovery meaningfully higher, sometimes well above 70% in younger, healthier men.
• Unilateral sparing. Saving just one bundle still helps, though the numbers drop and recovery tends to stretch out longer.
• Recovery timeline. Nerves heal slowly, and it can take six months to two years for function to return, which is normal, not a failure of the surgery.
• Robotic precision. So magnified 3D visualisation lets surgeons dissect closer to the nerves without the thermal damage older techniques often caused.

Much of this overlaps with what gets discussed during stage 2 prostate cancer planning too, where staging shapes strategy directly.

Yes, some ovarian cancer patients can still get pregnant, through an approach called fertility-sparing surgery that preserves the uterus and at least one healthy ovary while removing the cancer. This applies mainly to Stage IA disease, confined to one ovary, with a favourable grade and no sign of spread. Patient selection comes down to imaging, tumour markers, and pathology confirmed right there in surgery. Once the disease turns advanced or high-grade, complete removal stays the standard, closing off that option.

According to Prof. Dr. Sandeep Nayak, Best Surgical Oncologist in Bangalore, fertility preservation only makes sense when the cancer stays fully within safe margins. Confirming that on the table, not from a scan, is what actually protects the patient. That’s the whole point.

A handful of factors have to line up first. Not just one.

• Stage confined. The cancer sits entirely within one ovary, and imaging plus direct surgical exploration rule out any spread to the other side, the uterus, or nearby peritoneal surfaces.
• Grade matters a lot. Low-grade, well-differentiated tumours qualify far more often than aggressive ones, because grade tracks almost directly with how likely the cancer comes back.
• Capsule intact. Simple as that. Nothing ruptured during removal keeps the risk low enough to justify leaving healthy tissue in place.
• Clean washings. Always. Peritoneal fluid and biopsy samples taken mid-surgery have to come back completely free of malignant cells before anyone finalises anything.

Confirming all of this usually happens during pre-operative ovarian surgery planning, well before the final call on what gets preserved.

Care afterward shifts toward watching what’s left and mapping out what reproduction looks like next.

• Chemotherapy, sometimes. Certain tumour subtypes and grades still call for it even when the uterus and one ovary have been kept.
• Egg freezing helps. So when chemo can’t be skipped, talking through egg or embryo freezing beforehand protects fertility from what treatment might do to what’s left.
• Years of scans. Regular pelvic imaging and tumour marker checks continue well beyond surgery. Recurrence here is rare. Not impossible, just rare.
• Timing the pregnancy. Most oncologists say wait until surveillance confirms things are stable. The exact window shifts case by case, though. And honestly, that’s a conversation worth having early, not after the fact.

Patients often land here after an incidental finding first raised concern. That’s also where understanding ovarian cysts becomes part of the bigger picture.

Prof. Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery, with a fellowship in Laparoscopic and Robotic Onco-Surgery and over 24 years across genuinely complex oncological cases. He heads Oncology Services across Karnataka, leads Surgical Oncology and Robotic Surgery at KIMS Hospital, and he’s the one behind the RABIT, MIND, and L-VEIL surgical techniques.

Every ovarian cancer case at MACS Clinic goes through a full tumour board before fertility-sparing surgery is even offered. Because leaving healthy tissue behind only makes sense when the pathology genuinely backs it up. Patients who qualify walk into surgery knowing exactly what’s being preserved and why. Not a hopeful guess.

Call +91 8104310753 to book your consultation.

References

References

1. National Cancer Institute: Ovarian Cancer Treatment. https://www.cancer.gov/types/ovarian
2. World Health Organisation: Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, early-stage lung cancer can genuinely be cured without chemotherapy. For very early Non-Small Cell Lung Cancer specifically, surgical removal of the tumour is the standard, curative treatment on its own, and for a lot of patients at this stage, chemotherapy simply isn’t needed afterward at all.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “Patients hear a lung cancer diagnosis and immediately picture months of chemotherapy, and I understand why, that’s the association most people carry. But caught early enough, before it’s spread to lymph nodes or beyond, surgery alone often does the job completely. Chemo comes into the picture at later stages, not necessarily at this one.”

• Stage 1 Non-Small Cell Lung Cancer, where the tumour is small and hasn’t spread to lymph nodes, is often treated with surgery alone, no chemotherapy required afterward.
• VATS or robotic-assisted surgery removes the affected part of the lung with smaller incisions and faster recovery than traditional open surgery.
• Cure rates at this early stage, with surgery alone, are genuinely high, particularly when caught before any spread has occurred.
• Follow-up imaging and monitoring still continue after surgery, even without chemotherapy, to catch anything early if it does come back.

We’ve written in detail about how this surgical approach actually works in What Is VATS Surgery for Lung Cancer?, worth reading if surgery’s already on the table for your case.

• Once cancer’s reached the lymph nodes or spread further, chemotherapy usually becomes part of the plan alongside surgery, not instead of it.
• Tumour size and specific pathology findings after surgery can sometimes shift the plan, even in cases that looked early beforehand.
• Some patients get chemotherapy before surgery instead of after, depending on how the case is staged and planned.
• This decision always goes through a tumour board discussion, weighing the actual pathology against what surgery alone achieved.

If persistent respiratory symptoms are what brought you to this question in the first place, we’ve covered that separately in Persistent Cough: Can It Be Lung Cancer?, worth reading before jumping to conclusions about symptoms.

Dr. Sandeep Nayakhas spent more than two decades in surgical oncology, and early-stage lung cancer, treated with VATS and robotic-assisted surgery, has been a consistent part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that treatment doesn’t get over-escalated with chemo a patient doesn’t actually need, or under-treated when they genuinely do. That precision in matching treatment to stage is often where things get missed elsewhere.

Diagnosed early and not sure if chemo’s really necessary in your case? Get a clear answer before assuming either way. Call +91 9482202240 and get someone to actually walk you through it.

References

NCI — Non-Small Cell Lung Cancer Treatment (Health Professional Version)
ACS — Surgery for Non-Small Cell Lung Cancer

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, radiation therapy can sometimes lead to a second cancer later in life, though it’s genuinely rare. Radiation works by damaging the DNA of cancer cells, but healthy cells nearby the treatment area can take some of that damage too. Years down the line, in a small number of cases, that damage can turn into a new, separate cancer, sometimes a solid tumour, sometimes leukaemia.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “This is a real risk, I won’t pretend otherwise, but it needs to be weighed against what radiation actually does for the cancer sitting in front of us right now. For the vast majority of patients, the benefit of treating the existing cancer massively outweighs a small, long-term risk that may or may not ever materialise decades later.”

• Younger age at the time of radiation generally means a longer lifespan ahead for a second cancer to potentially develop, so children and young adults carry somewhat higher lifetime risk than older patients.
• Higher radiation doses and larger treatment areas are associated with greater risk compared to smaller, more targeted doses.
• The specific area treated matters, some tissues are more radiation-sensitive than others.
• Modern techniques, more precisely targeted than older radiation methods, have meaningfully reduced this risk compared to what patients faced decades ago.

We’ve written more about how modern radiation techniques are designed with this exact concern in mind in Understanding Radiation After Robotic Radical Prostatectomy, worth reading if precision and long-term safety are on your mind.

• The absolute risk of a second cancer from radiation is small, most patients who receive radiation never develop one.
• Regular follow-up after treatment is partly designed to catch anything unusual early, whether related to the original cancer or not.
• Not getting needed radiation to avoid a small future risk usually carries far greater risk from the cancer that’s actually being treated right now.
• This conversation is worth having directly with your radiation oncologist before treatment starts, not after, so you understand your specific risk profile.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and honest conversations about long-term treatment risk, radiation included, have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that risks get explained honestly and in proportion, not minimised and not exaggerated either. That straightforward approach is often where things get missed elsewhere.

References

NCI — Risk Factors: Radiation
ACS — Second Cancers

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Cancer caregivers can avoid burnout by setting boundaries that actually hold, asking for help from family and friends without guilt attached, taking regular breaks without feeling like you’re abandoning anyone, and genuinely prioritising your own health, sleep, food, and movement, alongside everything you’re doing for someone else.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “Families often show up entirely focused on the patient, which makes sense, but I’ve watched caregivers run themselves into the ground doing it. A caregiver who’s exhausted and depleted genuinely can’t support anyone well for long. Taking care of yourself isn’t selfish here, it’s actually part of taking care of them.”

• The role rarely comes with a break, appointments, treatment schedules, and daily care can stretch on for months without a clear end point.
• Guilt often stops caregivers from asking for help, even when family and friends genuinely want to be involved.
• Caregivers frequently put their own health, sleep, meals, exercise, on hold, telling themselves it’s temporary.
• Emotional exhaustion builds quietly, and it’s often only noticed once it’s already significant.

We’ve written about how families can stay close and supportive without added anxiety in Can I Hug My Family Member Going Through Chemo?, worth reading if you’re navigating the everyday, practical side of caregiving right now.

• Set boundaries early, decide what you can realistically take on and communicate it clearly rather than letting it build up silently.
• Ask for specific help, not vague offers, a friend who says “let me know if you need anything” usually needs an actual task to step in on.
• Build in regular breaks, even short ones, without treating them as something you need to justify or earn.
• Keep your own sleep, meals, and movement as non-negotiable, not the first things to get sacrificed when things get busy.
• Consider counselling or a caregiver support group, this isn’t a sign you’re not coping, it’s a genuinely useful resource.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and families navigating the caregiving side of a cancer diagnosis have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to families isn’t the title though, it’s that caregivers get seen too, not just the patient, with honest guidance on what’s sustainable and what isn’t. That attention to the whole family is often where things get missed elsewhere.

Supporting someone through cancer and running on empty yourself? You don’t have to manage that alone. Call +91 9482202240 and get someone to actually walk you through it.

References

NCI — Caring for the Caregiver
ACS — Caregiver Resource Guide

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.